Revenue Breakdown
Composition ()
No data
Revenue Streams
Cerus Corp (CERS) generates its revenue primarily from Product, which accounts for 100.0% of total sales, equivalent to $52.70M. Understanding this concentration is critical for investors evaluating how CERS navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Cerus Corp maintains a gross margin of 59.23%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.05%, while the net margin is -0.03%. These profitability ratios, combined with a Return on Equity (ROE) of -27.78%, provide a clear picture of how effectively CERS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CERS competes directly with industry leaders such as CLPT and ORGO. With a market capitalization of $442.76M, it holds a significant position in the sector. When comparing efficiency, CERS's gross margin of 59.23% stands against CLPT's 63.20% and ORGO's 75.97%. Such benchmarking helps identify whether Cerus Corp is trading at a premium or discount relative to its financial performance.
